Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 Oct 2;12:9435–9448. doi: 10.2147/CMAR.S272478

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2020 Shi et al.

This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).

PMC Copyright notice

MiR-634 exerted its role through targeting TPD52 in CC cells. (A-N) Hela and SiHa cells were transfected with NC mimics, miR-634 mimics, miR-634 mimics+pcDNA, or miR-634 mimics+TPD52. (A-D) QRT-PCR and Western blotting were conducted to analyze the levels of TPD52 mRNA and protein in Hela and SiHa cells. (E-L) CCK-8, plate clone, flow cytometry, and transwell assays were executed to evaluate the proliferation, colony formation, cell cycle progression, apoptosis, migration, or invasion of Hela and SiHa cells. (M and N) Western blotting was performed to assess the levels of cyclin D1, c-caspase 3, MMP-2, and MMP-9 in Hela and SiHa cells. *P < 0.05.